Tango Therapeutics TNGX Net Income
Net Income at other companies
Other financials
Where this comes from
Reported directly by Tango Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Tango Therapeutics’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Tango Therapeutics's net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Tango Therapeutics's net income?
- Tango Therapeutics (TNGX) reported net income of -$45.51M in Q1 2026.
- How has Tango Therapeutics's net income changed year-over-year?
- Tango Therapeutics's net income decreased by 14.1% year-over-year, from -$39.88M to -$45.51M.
- What is the long-term trend for Tango Therapeutics's net income?
- Over 4 years (2021 to 2025), Tango Therapeutics's net income has grown at a 14.9% compound annual growth rate (CAGR), from -$58.24M to -$101.59M.
- What does net income mean?
- The bottom line — total revenue minus all expenses, taxes, and costs. Represents the profit attributable to the company's shareholders after all obligations are met.